From Preclinical Pathway to Commercialization: Integrating the CKD Patient Voice at Every Stage of Drug Development

• Embedding patient advocacy organizations from preclinical pathway selection through to commercialization to ensure patient-centred design
• Co-developing study protocols informed by large-scale patient surveys and real-world insights to strengthen trial relevance
• Engaging patients early to refine endpoints, inclusion criteria, and study feasibility based on lived experience
• Creating ongoing partnerships between patients, scientists, and sponsors that inform both trial governance and long-term development strategy

Speakers:

Anthony Gucciardo

Senior Vice President - Strategic Partnerships,Program Development & Innovation

National Kidney Foundation